Following a four-way crossover protocol , two groups of eight patients with mild-to-moderate hypertension received a sodium-restricted diet ( 60 mmol daily ) and ingested single doses of 2.5 , 10 and 40 mg or 5 , 20 and 80 mg of CS-866 , respectively , or placebo .
